for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Philips buys U.S. cardiac care company BioTelemetry in $2.8 bln deal

AMSTERDAM, Dec 18 (Reuters) - Dutch health technology company Philips said on Friday it had agreed to acquire U.S. cardiac diagnostics and monitoring firm BioTelemetry in a deal which values the company at $2.8 billion.

Philips said it offered $72 per outstanding BioTelemetry share in cash, a 16.5% premium on the stock’s closing price on Thursday.

It expects to complete the acquisition in the first quarter of 2021. (Reporting by Bart Meijer; editing by David Evans)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up